Selenium treatment led to an improvement in the abnormal expression of Mfn2 and successfully ameliorated PCOS-related changes in the metabolic phenotype, thus suggesting that Mfn2 may play an essential role in the pathogenesis of PCOS. This evidence concerns the gene MFN2 and polycystic ovary syndrome.